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Abstract
The correct organization of single subunits of multi-protein machines in a three dimensional context is critical for their
functionality. Type III secretion systems (T3SS) are molecular machines with the capacity to deliver bacterial effector proteins
into host cells and are fundamental for the biology of many pathogenic or symbiotic bacteria. A central component of T3SSs
is the needle complex, a multiprotein structure that mediates the passage of effector proteins through the bacterial
envelope. We have used cryo electron microscopy combined with bacterial genetics, site-specific labeling, mutational
analysis, chemical derivatization and high-resolution mass spectrometry to generate an experimentally validated
topographic map of a Salmonella typhimurium T3SS needle complex. This study provides insights into the organization
of this evolutionary highly conserved nanomachinery and is the basis for further functional analysis.
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Introduction
One of the most exciting recent developments in the field of
bacterial pathogenesis is the discovery that many bacterial
pathogens utilize supramolecular nanomachines to deliver bacte-
rial proteins into eukaryotic cells. These proteins, which are
collectively referred to as effectors, have the capacity to modulate a
variety of cellular functions including cytoskeleton dynamics,
vesicle traffic, cell cycle progression and transcription. At least four
types of machines capable of transporting effectors have been
identified. They are known as type II, type III, type IV, and type
VI protein secretion systems [1–5]. Arguably the best understood
of these machines are the type III secretion systems (T3SS), which
are essential for the virulence of several important bacterial
pathogens including Salmonella enterica, Shigella spp., Yersinia spp.,
enteropathogenic strains of E. coli, and Vibrio cholerae. A central
component of T3SS is the needle complex, a multiprotein
structure that mediates the passage of the effector proteins through
the bacterial envelope. Although this structure was initially
identified in Salmonella enterica serovar typhimurium (S. typhimurium)
[6], it has been shown to be conserved in other bacteria encoding
T3SSs [7,8]. The cylindrically shaped needle complex is composed
of a multi-ring base (,25nm in width and ,30nm in length),
associated to the bacterial envelope, and a needle-like extension
that protrudes several nanometers (,20–50nm) from the bacterial
surface. The needle is anchored to the base through another
substructure, the inner rod, which together with the needle
filament forms a ,3nm wide channel that serves as conduit for the
proteins that travel this secretion pathway [9]. Assembly of the
needle complex occurs in discrete steps that first lead to the
assembly of the base substructure [10]. Once assembled, the base
begins to work as a secretion machine although exclusively
devoted to the secretion of the proteins required for the assembly
of the inner rod and the needle. Only upon complete assembly, the
secretion machine changes substrate specificity and becomes
competent for the secretion of effector proteins destined for
delivery into eukaryotic target cells [5]. This functional repro-
gramming is believed to involve significant conformational
changes in the needle complex itself [11].
S. typhimurium encodes two different T3SS within its pathoge-
nicity island 1 (SPI-1) and 2 (SPI-2), which in a coordinated
fashion mediate bacterial uptake into and replication within
epithelial cells. Previous biochemical and genetic studies have
established that the SPI-1-encoded S. typhimurium needle complex is
composed of the bacterial proteins PrgH, PrgK, and InvG, which
make up the base substructure, and PrgI and PrgJ, which
constitute the needle and inner rod substructures, respectively
[6,12]. Cryo electron microscopy and single particle analysis have
provided a ,17A ˚ resolution density map of the S. typhimurium SPI-
1-encoded needle complex [9]. Recently, atomic structures of
soluble domains of protein components from needle complexes
from various bacterial species have become available [13–15].
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within the main components of the base, which in the S.
typhimurium SPI-1 T3SS are InvG, PrgH and PrgK. Given the
fact that these three proteins apparently organize themselves in a
ring-like fashion, it has been proposed that this domain may
mediate the formation of these rings. Attempts have been made to
dock these protein domains into the needle complex structure.
However, the relatively low resolution of the available electron
microscopy density map does not allow the confident placement of
the atomic structures of the different protein domains without
additional experimental verification. Consequently, different, and
in some case mutually incompatible, locations have been proposed
for various protein domains [15,16].
In this study, we have used a combination of methods including
bacterial genetics, biochemistry, mass spectrometry and cryo
electron microscopy/single particle analysis to experimentally
assign specific protein domains to different substructures of the
needle complex. In addition, we have identified specific interaction
sites among components of the needle complex, which are critical
for its stable assembly. Combined, this analysis provides the first
experimentally validated topographic map of different components
of the needle complex of the S. typhimurium SPI-1 TTSS.
Results
InvG forms the outer rings and neck region and PrgH and
PrgK form the inner rings of the needle complex
The S. typhimurium needle complex component InvG belongs to
the secretin family, which is composed of outer membrane
proteins that are associated with several secretion systems in
Gram-negative bacteria. These include proteins associated with
type II (e.g. Klebsiella pneumoniae PulD) [17] and type III (e.g. Yersinia
spp. YscC) protein secretion systems [18], type IV pilus assembly
(e.g. Neiseria PilQ) [19] and filamentous bacteriophage secretion
(e.g. filamentous bacteriophage pIV) [20]. Secretins form higher-
ordered ring-like structures, which in the case of PulD are
organized in the form of two rings connected by a central disc.
This basic architecture creates two chambers of different size, one
of which extends with its N-terminal domain into the periplasmic
space as visualized by cryo electron microscopy of the trypsin
resistant core of the PulD complex [21]. Comparison of the PulD
structure with the needle complex shows striking similarities
between the PulD rings and the outer rings of the base
substructure of the needle complex. The similarities also extend
to regions of the neck of the needle complex, which connect the
outer rings with the inner rings (Fig. 1A). These similarities
strongly suggest that InvG forms the outer rings of the needle
complex of the SPI-1 T3SS base. However, this has not been
formally demonstrated and the extent to which InvG may form
the neck region of the needle complex has not been experimentally
determined. In order to ascertain what needle complex substruc-
tures are specifically formed by InvG, we purified needle
complexes from a DinvG mutant strain and analyzed their structure
by cryo electron microscopy and single particle analysis (Fig. 1).
Western blot analysis of the structures isolated from the DinvG
mutant showed the presence of PrgH and PrgK at equivalent
stoichiometry to that found in needle complexes isolated from wild
type (Fig. 1B). Structures isolated from this mutant strain showed
the presence of the inner ring 1 (IR1) and 2 (IR2) and an extending
needle-like structure but lacked the upper rings and the neck
region (Fig. 1C, E). Subtraction of two-dimensional class averages
of samples obtained from a DinvG mutant strain (Fig. 1E) from a
wild-type needle complex structure (Fig. 1D) revealed that InvG is
localized at the apical side of the needle complex forming the outer
ring structures and neck region (Fig. 1F). In comparison to PulD,
InvG extends further into the periplasmic space reaching the
largest inner ring (IR1) of the needle complex, presumably
anchoring the outer rings and thus stabilizing the base substruc-
ture.
The secondary structural features of PrgH and PrgK strongly
suggest that they form the inner rings of the needle complex base
although no direct evidence for this hypothesis has been presented.
Subtraction of two-dimensional class averages of samples obtained
from a DinvG mutant strain from the wild-type needle complex
structure also revealed that the ring structures from this mutant
strain are virtually identical to the inner rings of the wild type
needle complex (Fig. 1F). Since, beside PrgH and PrgK, the
needle and inner rod proteins are the only main structural
components of the DinvG substructure, these results formally
demonstrate that PrgH and PrgK make up the inner rings of the
base substructure. Taken together these results demonstrate that
InvG is the main component of the outer rings and connecting
neck of the needle complex while PrgH and PrgK are the main
components of the inner rings.
Localization and topology of PrgH within the base
substructure of the needle complex
Secondary structure prediction analysis indicates that PrgH
contains a transmembrane domain (from amino acid 142 to 162),
which would separate the protein into two soluble domains of
roughly equivalent size but distinct secondary structures (Fig. S1,
S2). The N-terminal domain is predicted to be rich in beta-sheets,
whereas the recently solved crystal structure of the major part of
the C-terminal domain (amino acids 170–362) showed that it has a
modular arrangement of similar a/b domains [15]. The
localization of the two soluble domains of PrgH relative to the
assembled needle complex, however, is still unclear. This
information is essential to guide the potential placement of the
recently solved atomic structure of a soluble domain of PrgH
within the protein density map of the needle complex. In order to
determine the topology of PrgH within fully assembled complexes
we constructed S. typhimurium strains expressing N- or C-terminal
Author Summary
Many Gram negative pathogens such as Salmonella,
Yersinia,o rShigella use the type III secretion system
(T3SS) to initiate infection in eukaryotic cells, resulting in
well known clinical symptoms ranging from mild head-
aches and diarrhea to life-threatening diseases such as
typhoid fever or bubonic plague. The T3SS is a highly
developed macromolecular system that serves as a
platform to make physical contact between host cells
and pathogens and mediates the translocation of bacterial
toxins (effector proteins) into eukaryotic cells. Central to
the T3SS is the mega-dalton sized membrane associated
needle complex, which is composed of several soluble and
membrane proteins; however, their organization within
the needle complex critical for proper assembly and
function is unclear. Here, we use an integrated experi-
mental approach that combines cryo electron microscopy
with bacterial genetics, site-specific labeling, mutational
analysis, chemical derivatization and high-resolution mass
spectrometry in order to determine the topographic
organization of individual components of the Salmonella
typhimurium needle complex and define sites critical for its
stability. Our study provides insights into the organization
of this evolutionary highly conserved system and is the
basis for further functional analysis.
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affect the functionality of the needle complex as assayed by its
ability to secrete the effector proteins SipB and SptP (Fig. 2A).
Needle complexes isolated from these strains were labeled with Ni-
NTA nanogold and analyzed by cryo electron microscopy and
single particle analysis. Class-averages showed that the labeled N-
and C-termini are located far away from each other, consistent
with the bioinformatic prediction that the different termini of
PrgH are topologically located on opposite sides of the inner
membrane (Fig. 2B and 2E). Classification of gold-labeled needle
complexes isolated from a strain expressing N-terminal poly-
histidine tagged PrgH showed additional density exclusively on the
cytoplasmic side of the base substructure suggesting that the N-
terminus of PrgH faces the cytoplasm (Fig. 2B). Moreover, in side
views of classified particles, the nanogold label can be seen at
various vertical and horizontal positions below IR2, presumably
due to a flexible tag and/or the existence of multiple copies of
PrgH that are organized in a cylindrical fashion and that are not
uniformly labeled by Ni-NTA nanogold. This observation is
consistent with the diffuse appearance of the additional ‘‘density’’
observed below IR2 in a class average of all the labeled particles
(Fig. 2C and D). In contrast, labeled needle complexes isolated
from a strain expressing C-terminal poly-histidine tagged PrgH
showed additional density above IR1 in close proximity to the
neck region (Fig. 2E–G). In this case, the labeling was visualized
as a distinct density, even in the class average of all particles
suggesting a more rigid conformation of this domain of PrgH.
Taken together, these results indicate that the amino terminus of
PrgH faces the bacterial cytoplasm while its carboxy terminus is
located within the periplasm of the bacterial envelope.
Localization of PrgK within the base substructure of the
needle complex
PrgK is a lipoprotein with a canonical sec-dependent
transport signal sequence that is processed upon secretion [6],
and a predicted single transmembrane domain (AA 207–227)
close to its carboxy terminus. Consequently, the large N-
terminal domain of PrgK (starting from Cys-18) is predicted to
be localized in the periplasm and anchored to the inner
membrane via its transmembrane domain. The atomic
structure of the PrgK homologue EscJ, which lacks a
transmembrane domain, revealed that this protein is organized
in two independent domains linked by a flexible linker [13,14]
(Fig. S1). Although EscJ carries a ‘ring forming’ motif similar
to that of PrgH and EscC (InvG) [15], EscJ rings have so far
never been isolated and/or visualized. To investigate the
topology of PrgK within the needle complex, we constructed S.
typhimurium strains expressing N- or C-terminal poly-histidine
tagged PrgK. Addition of the tag at the amino terminus
resulted in a loss of type III dependent protein secretion (data
not shown). In contrast, addition of the tag to the carboxy
terminus did not negatively affect needle complex function as
measured by SipB and SptP secretion (Fig. 3A). Needle
complexes isolated from this strain, labeled with Ni-NTA and
Figure 1. InvG forms the outer rings and neck region of the needle complex. (A) Cut-away view and description of individual substructures
of the needle complex from S. typhimurium. (OR outer ring; IR inner ring) Bar=10nm. (B–F) Analysis of complexes obtained from a S. typhimuirum
DinvG strain: Western blot analysis (B), cryo electron microscopy images (C), and class averages of non-tilted complexes, (D, E) isolated from wild type
and DinvG mutant S. typhuimurium strains, respectively. (F) Density difference between averaged images of wild type needle complexes and DinvG
mutant complexes (1F=1D-1E), indicates the position of the outer ring substructure.
doi:10.1371/journal.ppat.1000824.g001
Type III Secretion Complex Topology
PLoS Pathogens | www.plospathogens.org 3 April 2010 | Volume 6 | Issue 4 | e1000824examined by cryo electron microscopy and single particle
analysis showed additional density exclusively on the cytoplas-
mic side of the base substructure (Fig. 3B). These results
indicate that the carboxy terminal domain of PrgK faces the
cytoplasm. Comparison of the position of the nanogold label on
the C-terminus of PrgK (Fig. 3C) with that of the N-terminus
of PrgH (Fig. 2C) by subtracting the total class averages from
wild type (Fig. 1D) showed a more distinct localization of the
nanogold label in PrgK (Fig. 3D, 2D). This observation
suggests that the C-terminus of PrgK is less flexible than the N-
terminus of PrgH and positioned closer towards the cup region
o ft h en e e d l ec o m p l e x( Fig. 1A, 3E).
Localization of PrgH and PrgK within IR1 and IR2
In order to refine the relative position of PrgH within the inner
rings we constructed a strain of S. typhimurium that expresses a
PrgH mutant in which we introduced a poly-histidine insertion
linker after amino acid 267 (PrgH-267
his)( Fig. S3). The resulting
strain expressed a functional T3SS system as shown by its ability to
secrete the effector proteins SipB and SptP (Fig. 4A). Needle
complexes isolated from this strain were labeled with Ni-NTA-
nanogold and examined by cryo electron microscopy and single
particle analysis. Additional density at the widest part of the IR1
(Fig. 4B, 4C, Fig. S4) was readily observed, indicating that PrgH
is located at the periphery of IR1.
Figure 2. The N- and C-terminus of PrgH are located far away from each other within the needle complex. (A) N- and C-terminally poly-
histidine tagged PrgHs are functional. Culture supernatants of a wild type S. typhimurium (w.t.), PrgH-deficient (DprgH), and mutant strains encoding
either N- (his-PrgH) or C-terminally (PrgH-his) poly-histidine tagged PrgH were analyzed for the presence of the type III secreted proteins SipB and
SptP by Western immunoblot. (C: whole cell lysates; S: culture supernatants). (B, E) Representative class averages obtained by single particle analysis
of cryo electron microscopy images of Ni-NTA-labeled needle complexes derived from strains expressing either N-terminally (B) or C-terminally (E)
tagged PrgH. (C, F) The total class averages (average of all particles) from the respective data set are shown in (C) (N-terminally labeled PrgH) and (F)
(C-terminally labeled PrgH). The diffuse appearance of density at the basal side in (C) indicates that the Ni-NTA-nanogold (Au) label is present in
various positions below IR2, but is more restricted above IR1 in C-terminally labeled complexes (F) (IR1 and IR2=inner ring 1 and 2). (D, G) Density
difference between the total averages of the labeled particles and unlabeled wild type complexes (panel D: w.t. needle complexes subtracted from
labeled N-terminally tagged complexes (2D=2C-1D); panel G: w.t. needle complexes subtracted from labeled C-terminally tagged complexes
(2G=2F-1D)).
doi:10.1371/journal.ppat.1000824.g002
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an outer ring formed by PrgH [15]. This model was based on the
crystallographic analysis of the PrgK homolog EscJ, which
crystallized in a superhelical fashion. Subsequent modeling led
to an approximately 180A ˚ wide ring structure, which was
proposed to be anchored to the inner membrane by the lipidated
N-terminal cysteine of EscJ/PrgK. In this model, the EscJ/PrgK
ring would be located on top of the outer leaflet of the inner
membrane projecting into the periplasmic space [14]. An
alternative model proposed for MxiJ, the Shigella spp. homolog
of PrgK, positions this protein as radial spikes enclosed by an
outer ring [16]. To gain insight into the organization of PrgK
within the needle complex, we sought to obtain top views of the
inner rings of the needle complex by electron microscopy for
subsequent single particle analysis, which required the removal of
the InvG rings. The proximity of the C-terminus of PrgH to InvG
suggested the possibility that truncating the C-terminus of PrgH
could weaken the interaction between these two proteins. We
therefore constructed a S. typhimurium strain that expresses a PrgH
mutant lacking its last 4 amino acids (PrgH
D4). The resulting
strain expressed a functional T3SS as shown by its ability to
secrete effector proteins (Fig. 4A) and the presence of intact
needle complexes (Fig. 4D). However, when subjected to high
pH treatment, the needle complexes not only disassembled the
needle filament over time [9], but, in contrast to wild type, upon
negative staining the complexes obtained from this mutant strain
could be further disassembled to generate intact inner rings (IR1/
IR2) separated from the smaller outer rings (Fig. 4D). We
analyzed the inner rings (IR1/IR2) thus obtained by electron
microscopy without imposing any symmetry or introducing any
potential model bias. This analysis showed the presence of several
concentric rings with different staining intensities (Fig. 4E). The
two concentric rings with the larger diameter (,250A ˚ and
,180A ˚) exhibited repeating subunits separated every 15 degrees
thus resulting in a 24-fold symmetry. The accessibility of PrgH-
267
his to surface labeling and the appearance of additional
density on the outermost surface of IR1 strongly suggested that
the largest ring visualized in the inner ring particles must be made
up by PrgH. On the other hand, the size, configuration, and
density distribution of the second largest ring with an approx-
imate diameter of 180A ˚ are consistent with the hypothesis that
this ring is formed by PrgK (Fig. 4E, G, Fig. S6). If this were
the case, most of PrgK would be buried by the presence of InvG
(top) and PrgH (outside). Consequently, this model would also
predict that removal of InvG should expose otherwise buried
residues. To test this hypothesis, we compared the ratio of
accessibility of lysine residues of PrgK in complexes isolated from
wild type or DinvG S. typhimurium strains (which exposes the apical
side of IR1, see Fig. 1) by subjecting the isolated particles to
acetylation using NHS-acetate and subsequent analysis by mass
spectrometry. Lysine 168 from PrgK was found to be more
frequently (.15 times) acetylated in tryptic peptides derived from
PrgK obtained from complexes from a DinvG mutant strain than
in PrgK peptides obtained from wild type needle complexes
(Fig. 4F, Table S1). Consistent with this observation, modeling
of PrgK using the EscJ structure as a template (see below) showed
that the side chain amino group of K168 would be surface
exposed in the absence of InvG (Fig. 4G).
Figure 3. The C-terminus of PrgK is located at the basal (cytoplasmic) side of the needle complex. (A) Carboxy terminally poly-histidine
tagged PrgK is functional. Culture supernatants of wild type S. typhimurium (w.t.), PrgK-deficient (DprgK), and a mutant strain encoding C-terminally
(PrgK-his) poly-histidine tagged PrgK were analyzed for the presence of the type III secreted proteins SipB and SptP by Western immunoblot. (C:
whole cell lysates; S: culture supernatants). (B) Representative class averages obtained by single particle analysis of cryo electron microscopy images
of Ni-NTA-labeled needle complexes derived from strains expressing C-terminally poly-histidine tagged PrgK. (C) Total class average of Ni-NTA-
labeled needle complexes obtained from a S. typhimurium strain expressing C-terminally poly-histidine tagged PrgK. The location of the density
observed at the basal side (Au) is similar to the diffuse density observed in Ni-NTA-labeled needle complexes obtained from strains expressing N-
terminally poly-histidine tagged PrgH (see Fig. 2C) (IR1 and IR2=inner ring 1 and 2). (D) Resulting difference in density after subtraction of w.t.
needle complexes from labeled C-terminally poly-histidine tagged PrgK complexes (3D=3C-1D). (E) Subtraction of the total averages of labeled
complexes obtained from a strain expressing N-terminally-tagged PrgH from a strain expressing C-terminally-tagged PrgK (3E=3D-2C).
doi:10.1371/journal.ppat.1000824.g003
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PLoS Pathogens | www.plospathogens.org 5 April 2010 | Volume 6 | Issue 4 | e1000824Figure 4. Organization of PrgH and PrgK within the lower ring of the needle complex. (A) Insertion of a poly-histidine linker at amino acid
267 of PrgH (267
his) or removal of four amino acids from its C-terminus (D4) does not alter its function. Culture supernatants of wild type S.
typhimurium (w.t.), PrgH-deficient (DprgH), and mutant strains encoding a poly-histidine linker at amino acid 267 of PrgH (267
his) or a PrgH lacking the
terminal four amino acids (D4) were analyzed for the presence of the type III secreted proteins SipB and SptP by Western immunoblot. (C: whole cell
lysates; S: culture supernatants). (B) Representative class average obtained by single particle analysis of cryo electron microscopy image of Ni-NTA-
labeled needle complexes obtained from a S. typhimurium strain expressing PrgH with a poly-histidine tag inserted at amino acid 267. A prominent
gold label (Au) is seen at the widest side of the periplasmic face of the IR1 (IR1 and IR2=inner ring 1 and 2). Bar=10 nm. (Additional results of the
analysis are shown in Fig. S4). (C) Resulting difference in density after subtraction of unlabeled w.t. needle complexes from labeled complexes
isolated from strains expressing a poly-histidine insertion following amino acid 267 in PrgH. (D) Mutant needle complexes carrying truncated PrgH
can be selectively disassembled into larger and smaller rings by shifting pH to 10.5 and subsequent negative staining, whereas wild type (w.t.) needle
complexes maintain the integrity of the base. (E) En face class-average derived from single particle analysis from negatively stained electron
microscopy images of inner rings substructures. The substructures were obtained by selective disassembly of needle complexes isolated from a
mutant strain encoding for a C-terminally, four amino acid truncated PrgH. The ring substructure is organized in two larger concentric rings with
different diameters (,180A ˚ and ,250A ˚). Bar=10nm. Rotational cross-correlation analysis revealed that the maximum of the cross-correlation peak is
repeatedly obtained every 15u, demonstrating that the larger concentric rings of the inner ring structure from the prgHD4 mutant strain exhibit 24
fold symmetry. (F) Surface accessibility of lysine K168 is increased in complexes obtained from a S. typhimurium DinvG strain. Primary amines of wild
type and DinvG mutant complexes were acetylated with Sulfo-NHS-Acetate and the ratio of modified to non-modified peptides was determined by
mass spectrometry. Each bar represents the ratio of acetylation of lysines between specific PrgK peptides obtained from the DinvG mutant and the
same peptides obtained from a wild type complex (Table S1). The ratio of peptide acetylation is an average of two independent mass spectrometry
measurements. (G) Lysine 168 is surface exposed in modeled PrgK rings. A monomeric PrgK structure was modeled using EscJ as a template and
protein-protein contacts present in the EscJ crystal structure were used to form a PrgK ring (top and side view). Lysine 168 is located on top of the
ring and its side group nitrogen is surface exposed as highlighted in blue in the surface view of the cut-out segments of individual monomers. The
cut-out segment shows two PrgK molecules in surface representation (yellow and light-yellow) followed by one neighboring molecule on each side
but displayed in ribbon style.
doi:10.1371/journal.ppat.1000824.g004
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composed of two larger concentric rings: a peripheral ring formed
by PrgH enveloping an inner ring formed by PrgK, which is
shielded by PrgH (on the sides) and InvG (on the top).
Domain interactions among components of the type III
secretion needle complex characterized by cross-linking
and mass spectrometry
In order to refine the spatial relationship between the domains
of the different proteins that make up the needle complex and to
gain insight into the nature of potential domain-domain
interactions, we used chemical cross-linking combined with high-
resolution mass spectrometry. Purified needle complexes were
incubated with the bi-functional cross-linking agent BS2G (d0/d4),
which is able to covalently link primary amino groups at a distance
up to ,8A ˚. Particles in which two or more complexes were cross-
linked were separated from individual ones by re-purification on
sucrose gradients, and tryptic fragments generated from these
complexes were analyzed by mass spectrometry after protease
digestion in solution. Several cross-links were identified between
the different domains of InvG, PrgH, and PrgK (Fig. 5A,
Table 1). A single cross-link between InvG (K38) and PrgH
(K367) was found, establishing that the N-terminal domain of
InvG and the C-terminal domain of PrgH are in close contact.
This is also consistent with the observation that truncation of four
amino acids from the carboxy terminal end of PrgH resulted in the
destabilization of the needle complex (Fig. 4D) and supports the
notion that the interaction of PrgH with InvG is very important for
the linkage of these two substructures. From strains with longer
truncations at the C-terminus of PrgH only complexes similar to
those obtained from a DinvG mutant strain could be purified (data
not shown), further demonstrating the importance of this domain
for needle complex assembly.
We found two clusters of residues of the amino terminus of
PrgH that cross-linked to the C-terminal end of PrgK (Table 1
and Fig. 5A). In addition to the primary amino group at the N-
terminal end of the protein, lysine residues at position 5, 132, and
133 of PrgH were found to cross-link to lysine residues at position
239, 246 and 248 of PrgK. The linkages found exclusively between
the N-terminal domain of PrgH and the C-terminal tail of PrgK
are in full agreement with the results obtained from the nanogold
labeling experiments. The absence of any cross-links from the
large N-terminal domain of PrgK is also consistent with the
proposed concentric arrangement of PrgK shielded by PrgH and
InvG.
Topology model of the S. typhimurium needle complex
components
To construct a model for the topological arrangement of the
components of the S. typhimurium needle complex, we used the
available crystal structure of PrgH and modeled InvG and PrgK
using the structures of their close homologues EscC and EscJ,
respectively (Text S1). In addition, we incorporated in such model
all of our experimental findings described above. The model shows
that the N-terminal domain of PrgH and the short C-terminal
domain of PrgK are in close contact at the cytoplasmic face of the
needle complex (Fig. 5B). Furthermore, the N-terminal domain of
InvG is localized at the lowest part of the neck-region oriented in
such a way that allows its interaction with the C-terminal domain
of PrgH (Fig. 5B, Fig. S7). This arrangement is supported by the
finding of cross-linked peptides [IPVTGSGFAVK38DDSLR]-
[DDWLK367G] encompassing these two domains (Table 1).
The C-terminal PrgH peptide, however, is not visible in the
atomic structure, hence this interaction can not be incorporated
into a high-resolution model building (Fig. 5D).
Several models involving 12 or 14 fold symmetries have been
proposed for the N-terminal region of the InvG homologue EscC.
These ring models were placed at different positions within the
needle complex depending on the proposed symmetries and
correlating different volumes and diameters [15]. Our data
indicate that the amino terminus of InvG should face the inner
rings, which provides an unambiguous orientation to the InvG
ring that is incompatible with some of the previously proposed
models [15,16]. However, our data cannot clarify the issue of the
differing symmetries in the proposed models, which would require
experimental data at a sufficiently high resolution to show
individual subunits within the outer ring and neck region.
PrgH and PrgK are the main constituents of the inner rings.
Nanogold labeling of a needle complex isolated from strain
expressing a PrgH mutant derivative with a his-tag after position
267 resulted in an additional density on the outer perimeter of the
IR1. This observation led us to manually position the C-terminal
domain of PrgH in such a way that amino acid 267 would be
located at the periphery of IR1 (Fig. 5C, E, Fig. S7). The
positioning of PrgK in our model takes into account the
crystallographic contacts between the monomers observed in its
homologue EscJ, resulting in a ring of roughly the same diameter
to that proposed for EscJ. In our model we have also positioned
the PrgK ring in such a way that PrgK K168 faces the periplasm,
to account for our observation that K168 becomes accessible for
derivatization in the absence of InvG (Fig. 5C, E, Fig. S7).
Discussion
The atomic structures of several soluble domains of needle
complex components have become available. Attempts have been
made to place those domains within the available structures of the
entire needle complex to begin to generate an atomic model of the
entire structure. However, the low resolution of the available needle
complex structure has significantly hampered this objective and has
prevented theunambiguous assignmentofspecific domainstospecific
protein densities within the needle complex. The cylindrical
architecture of the needle complex further complicates the docking
since, depending on the assumed stoichiometry or subunit number,
modeled ring-like structures can be placed at different positions
within the needle complex. Consequently, different studies have
proposed incompatible locations for different proteins and/or protein
domains within the needle complex [15,16]. We have used a multi-
pronged approach to generate data allowing us to place domains of
different protein components of the needle complex at specific sites of
its structure. We have experimentally shown that InvG forms the
outer rings. Although widely predicted from secondary structure
analysis as well as the organization of homologues in other secretion
systems (e.g. PulD family of proteins), this is the first experimental
demonstration of this organization. Furthermore, our data demon-
strated that InvG reaches deep into the periplasmic space making up
the entire neck region and making direct contact with the inner rings,
and in particular, the carboxy terminal domain of PrgH. Although
the C-terminus of PrgH is not visible in the atomic structure therefore
hindering high-resolution model building, the interaction between
this domain and the amino terminus of InvG appears to be critical for
the stability of the entire complex.
Our data also demonstrates that PrgH and PrgK are the main
constituents of the inner rings. Our results indicate that the C-
terminal domain of PrgH is localized at the periphery of IR1, as
supported by the nanogold label of a tag introduced between
amino acid 267 and 268, Fig. 4B and 4C). As previously
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smaller diameter ring structure engulfed by the PrgH ring on the
side and covered by the InvG neck region on top.
Multicomponent macromolecular complexes are central to
many fundamental processes in biology. To gain insight into
mechanistic details, knowledge not only of the atomic structure of
the different subunits, but also their orientation relative to one
another is essential. Therefore, our studies offer an essential view
of the architecture of this remarkable bacterial nanomachine and
will be the basis for further functional studies.
Materials and Methods
Bacterial strains and plasmids
All strains were derived from the non-flagellated S. enterica
serovar typhimurium strain SJW2941. The invG, prgH, and prgK
mutant alleles were introduced into this strain by P22HTint-
mediated transduction as described elsewhere [22]. The needle
complexes lacking InvG were purified from the strain SB1171 (all
‘‘SB’’ strains are described elsewhere) [10]. PrgH modified needle
complexes were obtained by complementing the strain SB906,
which harbors a chromosomal deletion of prgH, with plasmids
expressing C-terminal truncated PrgH, an 18x-C-terminal, a 6x-
N-terminal, or a 6x internal (after M267) poly-histidine tagged
PrgH. A longer C-terminal poly-histidine tag was chosen because
a 6xhistidine-tag yielded a poor Ni-NTA-NanoGold label. All
plasmids were based on the low copy vector plasmid pWSK29 and
expressed the tagged PrgH under its natural promoter (500bp
upstream sequence). The w.t. strain SB905 was used as a negative
control for the Ni-NTA-NanoGold labeling experiments and for
the detection of adjacent epitopes by mass spectrometry. An allele
of PrgK with a C-terminal 6x-poly-hisitidine tag was introduced
into SB905 by homologous recombination as described previously
[22]. Plasmids expressing the hilA positive transcriptional regulator
Figure 5. Domain interactions and relative orientations of needle complex components. (A) Proximity of specific domains of the base
proteins, InvG, PrgH, and PrgK within the needle complex. The block diagrams shows the three major base proteins, InvG, PrgH, and PrgK and
covalent cross-links of peptides obtained from chemically derivatized needle complexes at primary amino groups. Amino acid position are indicated
for the full length proteins prior signal peptide cleavage (processed InvG starts at Ser-25, and processed PrgK starts at Cys-18 [6]) protein-cross-links
found are indicated with amino acid position and with crossing lines between proteins. While the position of non-derivatized lysines (presumably due
to lack of surface exposure) is shown as vertical lines within the block diagram, the positions of derivatized lysines (surface accessible) is indicated as
vertical lines extending from the block diagram (Table S2). Note that lysines within the N-terminal domain of PrgK are not derivatized, suggesting
that the majority of PrgK within fully assembled needle complexes is not surface exposed. (B–E) Topographic model of the needle complex:
Localization of InvG, PrgH, and PrgH within the base of the needle complex. The N-terminal domain of InvG (blue-grey) reaches far down into the
neck region and is in close contact with the C-terminal domain of PrgH (white and grey), which resembles the larger of the two concentric rings.
Insertion of a poly-histidine tag between amino acid 267 (yellow) and 268 (orange) and subsequent Ni-NTA nanogold labeling further determines the
position of this domain within the complex. Sites of interaction found by cross-linking and mass spectrometry, for which in the case of PrgH and EscJ/
PrgK no atomic structure is available, are labeled as red dots. The N-terminal domain of PrgH is pointing to the cytoplasmic side of the complex, and
interacts with the C-terminal domain of PrgK. For both, no high resolution structure is available as of yet. The N-terminal domain of PrgK is located
within the complex and is therefore packed into its position by PrgH from the side and InvG from the top. (C) Top and side view of the modeled PrgH
(white/grey alternating) and PrgK (yellow/bright yellow alternating), as well as sites accessible for nanogold labeling (267/268) and chemical
derivatization (K168). (D) Proposed relative position of protein domains from PrgH, InvG, and PrgK. The side group nitrogen of K38 (InvG) and K168
(PrgK) are highlighted in blue. (E) Top-view of three PrgK and PrgH monomers extracted from the modeled inner ring structure highlighting sites for
chemical derivatization (PrgK (K168, blue)) and Ni-NTA nanogold labeling of a poly-histidine insertion at position 267/268 (yellow/orange) within
PrgH.
doi:10.1371/journal.ppat.1000824.g005
Table 1. List of hetero-cross-linked peptides determined by chemical derivatization and mass spectrometry.
Crosslinked proteins Crosslinked lysines Peptide1 Peptide2 Mass Error (ppm) xQuest Score
InvG-PrgH K38—K367 IPVTGSGFVAKDDSLR DDWLKG 2.1 17.7
PrgH-PrgK N-Term-K239 METSK KGITADDK 1.3 25.8
PrgH-PrgK N-Term-K246 METSK GITADDKAK 1.3 26.7
PrgH-PrgK N-K248 METSK KGITADDKAK 0.7 19.1
PrgH-PrgK N-K248 METSK AKSSNE 1.1 20.5
PrgH-PrgK K5-K239 METSKEK KGITADDK 0.5 21.4
PrgH-PrgK K5-K246 METSKEK GITADDKAK 1.0 18.4
PrgH-PrgK K5-K248 METSKEK AKSSNE 0.0 15.4
PrgH-PrgK K132-K239 LETSAKK KGITADDK 1.4 23.4
PrgH-PrgK K132-K246 LETSAKK GITADDKAK 0.9 15.2
PrgH-PrgK K132-K248 LETSAKKA KSSNE 1.0 22.4
PrgH-PrgK K133-K239 KNEPR KGITADDK 1.1 21.2
PrgH-PrgK K133-K246 KNEPR GITADDKAK 1.3 24.7
PrgH-PrgK K133-K248 KNEPR AKSSNE 1.7 17.8
Only peptides with an xQuest score of higher than 15 are displayed as those cross-linking results are likely to be reliable [25] (Text S1). The respective modified amino
acid is displayed in bold. Under ‘‘Crosslink’’ listed positions are the absolute positions of the respective protein (including signal peptides), ‘‘Error’’ the deviation of
measured precursor ion mass from theoretical precursor ion mass in parts per million, and ‘‘Score’’ the xQuest score.
doi:10.1371/journal.ppat.1000824.t001
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were used to over-express the SPI-I TTSS regulon as described
elsewhere [23].
Bacterial secretion assay
The preparation and analysis of cultured supernatant proteins
was conducted as described elsewhere [22].
Needle complex expression and purification
Needle complex purification was based on the purification
protocol previously published [9]. Needle complexes were
purified from 2 L of bacterial culture. For the strain SB1171
the protocol was up-scaled to 18 L of bacterial culture to obtain
a yield comparable to the other strains. Details are provided
under Text S1. To further improve purity of the sample or to
separate inter-particularly cross-linked particles from single
particles, a sucrose gradient centrifugation was performed. A
continuous 10–25% sucrose gradient in thin-wall tubes of the
Sorvall TH-660 rotor was made with a 0.1% LDAO, 10 mM
sodium phosphate (pH 7.4), 0.5 M NaCl buffer. The sample
was applied to the top of the gradient and centrifuged for
3.5 hours at 50 krpm. Two 1.1 ml and four 0.45 ml fractions
w e r ec o l l e c t e df r o mt h et o po ft h et u b ea n dw e r ed i l u t e di n
sucrose-free buffer and pelleted at 90 krpm for 30 minutes in a
Sorvall S100-AT4 rotor. The pellets were re-suspended in
0.1 ml 0.1% LDAO, 10 mM sodium phosphate (pH 7.4), 0.5 M
NaCl. Integrity and purity of the sample was verified by
negative stain EM and SDS-PAGE.
Disassembly of needle complexes to inner and outer
rings
The needle filament was removed by incubating purified needle
complexes in 10 mM sodium phosphate (pH 10.4), 0.5 M NaCl,
0.1% LDAO for 15 min at 37uC. Subsequently the pH was re-
adjusted by purifying the sample by sucrose gradient centrifuga-
tion as described above. The sample was observed by negative
stain electron microscopy as described below.
Ni-NTA-NanoGold labeling of poly-histidine-tagged
needle complexes
Samples tending to aggregate (His-PrgH, PrgK-His) were
purified in presence of 10mM imidazol. Free thiols of sucrose
gradient purified needle complexes were blocked by incubating the
sample with 1 mM N-ethylmaleimide at 4uC over night.
Subsequently, imidazole was added to a concentration of
20 mM and the sample was incubated with 5 mM nickel-
nitrilotriacetic acid (Ni-NTA) NanoGold (Nanoprobes, Stony
Brook, NY) at room temperature for 10 minutes. The sample
was gel-filtrated with a Sephacryl 300 column to remove unbound
Ni-NTA-NanoGold and analyzed by cryo-electron microscopy.
Chemical derivatization, mass spectrometry (MS) and MS
data analysis
Chemical derivatization was performed by incubating sucrose
gradient purified sample (about 1mg/ml) on ice with 600 mM
Sulfo-NHS Acetate (Pierce, Rockford, USA) for 60 minutes or
200 mM BS2G-d0/d4 (Pierce, Rockford, USA) for either 30 or
60 minutes.. Details about chemical derivatization and subsequent
MS analysis are provided in Text S1.
Electron microscopy and image processing
Samples were applied to glow-discharged carbon-coated 400
mesh hexagonal Cu/Pd-grids. For negative stain images 5 mlo f
sample was applied to the grid and subsequently stained with 2%
PTA (phosphotungstate), pH 7.0 (Fig. 4D) or NanoVan (Nanop-
robes, Stony Brook, NY) (Fig. 4E, Fig. S5). Overview images
were acquired at 44,000-fold magnification in a Morgani TEM
(FEI Company, Hillsboro, USA) at 80kV using an 11 megapixel
CCD camera. High-resolution data was collected with a FEI
Tecnai Polara at 300kV using a Gatan Ultrascan 4000 UHS CCD
camera (16 mega-pixel, 4k64k, 15 micron pixel size). Images were
acquired at 112,968-fold magnification, which corresponds to
1.33 A ˚/pixel at the level of the specimen, with underfocus values
ranging from 1.2–3.5 mm.
For cryo electron microscopy 5 ml sample was applied to glow-
discharged grids before vitrification by plunge freezing in liquid
ethane. Low-dose data was collected with a FEI Tecnai Polara at
300kV using a Gatan Ultrascan 4000 UHS CCD camera (16
mega-pixel, 4k64k, 15 micron pixel size). Images were acquired at
71,949-fold magnification (2.08 A ˚/pixel) with under focus values
ranging from 1.2–3.5 mm.
Individual particle projections were extracted, combined into a
dataset and processed by IMAGIC-5 (Image Science Software
GmbH, Germany). The contrast reversals imposed by the contrast
transfer function (CTF) of the objective lens were corrected for
each particle projection using the mean under focus value of the
respective CCD-images as determined by the program
CTFFIND3 [24].
Supporting Information
Text S1 Supplementary Information Protocols
Found at: doi:10.1371/journal.ppat.1000824.s001 (0.05 MB RTF)
Figure S1 Block diagram of the three major base proteins, InvG,
PrgH, and PrgK of the needle complex and region of atomic
structures of PrgH and the homologues EscC (InvG) and EscJ
solved. Vertical lines extending from the block diagram are
positions of lysines that can be chemically derivatized and are
presumably surface exposed. Remaining non-derivatizable (and
probably not surface exposed) lysines are indicated as vertical lines
within the block diagram.. Amino acid position for InvG, PrgH,
and PrgK are indicated for the full length proteins prior signal
peptide cleavage (processed mature InvG starts at Ser-25, and
PrgK starts at Cys-18, respectively).
Found at: doi:10.1371/journal.ppat.1000824.s002 (2.84 MB TIF)
Figure S2 Sequence alignment and secondary structure predic-
tion of the major part of the N-terminal domain of PrgH (1–122)
from various species (S. typhimurium (PrgH), E. coli (EprH), Y.
enterocolitica (Ye3550), S. flexneri (MxiG)). The N-terminal
domain of PrgH is predicted to be mostly composed of beta-
strands. Highly conserved and similar residues are indicated in
red.
Found at: doi:10.1371/journal.ppat.1000824.s003 (0.47 MB TIF)
Figure S3 Ribbon diagram of PrgH (177–362) and position for
insertion of a poly-histidine tag following amino acid 267 for Ni-
NTA-nanogold labeling.
Found at: doi:10.1371/journal.ppat.1000824.s004 (0.23 MB TIF)
Figure S4 Single particle analysis of Ni-NTA labeled needle
complexes with a poly-histidine insertion following position 267 in
PrgH. Representation of various views of class-averages, variance-
images, and individual particles of PrgH-267
his labeled needle
complexes show the presence of the nanogold label at the
outermost perimeter of the inner rings. The highest variance was
observed at the position of the nanogold label, which indicates that
the individual particles are not uniformly labeled. This is also
evident, when individual particles are visualized.
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Figure S5 PrgK resembles the smaller concentric ring of the
PrgHD4 inner ring substructure. En face view of the most
prominent class-average derived after hierarchical clustering from
images of negatively stained inner rings substructures from
PrgHD4 complexes. The smaller concentric ring shares similarity
in dimension (,180A ˚) and organization to the modeled PrgK ring.
In order to allow a comparison between the class average of the
inner ring substructure and the modeled PrgK ring, only a
segment of the latter is shown.
Found at: doi:10.1371/journal.ppat.1000824.s006 (0.53 MB TIF)
Figure S6 Ribbon diagram of modeled InvG and PrgK
domains. The structure of InvG (white) and PrgK (yellow) were
obtained by structure homology-modeling based on EscC (blue)
and EscJ (blue) templates, using the SWISS-MODEL server
(http://swissmodel.expasy.org/). Note that in EscJ Asn134 to
Gln139 is not resolved in the X-ray structure, however, the
corresponding amino acids in PrgK (Asp133 to Lys144) have been
modeled using the the SWISS-MODEL server, indicating a
possible conformation of this amino acid stretch (marked with an
*). This domain (also marked with an *) is shown with a 70%
transparency setting in Fig. S7.
Found at: doi:10.1371/journal.ppat.1000824.s007 (0.43 MB TIF)
Figure S7 Overview of needle complex substructures and
organization. Side view of half-sectioned base and location of
individual protein domain. (* indicates to a possible confirmation
of amino acids 133–144 in PrgK based on modeling using the
SWISS-MODEL server (Fig. S6). Concentric ring-organization of
IR1/2 revealed from top-viewed disassembled complexes and ring
models of PrgH and PrgK.
Found at: doi:10.1371/journal.ppat.1000824.s008 (1.48 MB TIF)
Table S1 Comparison of surface accessibility in wild type and
DinvG mutant complexes. Peptides from NHS-acetate derivatized
complexes were identified by MS/MS sequencing and semi-
quantified by MS peak integration (Text S1). The table displays
the modified lysine (Lysine), the identified corresponding peptide
(Peptide) and the degree of NHS-acetate modification for the wild
type (%w.t.) and the DinvG mutant (%DinvG). The ratio of
peptide acetylation is an average of two independent mass
spectrometry measurements. To highlight which lysines get
stronger modified in the DinvG mutant (and are most likely more
surface exposed) the ratio of DinvG mutant and wild type
acetylation is determined (%DinvG/%w.t.). Due to the presence
of several lysines within the peptides ‘‘K48, K53’’ and the C-
terminally located peptides (‘‘C-term’’=K238, K239, K246,
K248) the exact position of the derivatization could not be
distinguished.
Found at: doi:10.1371/journal.ppat.1000824.s009 (0.07 MB RTF)
Table S2 List of mono-links and loop-links determined by
chemical derivatization and mass spectrometry. In order to specify
all lysines being accessible for derivatization, hetero-cross-links
(cross-link between two different proteins, see Table 1), mono-links
(modified peptides that reacted with only one functional group of
the bivalent cross-linker (BS2G (0/d4))) and loop-links (cross-links
within one polypeptide chain or between homo-proteins) were
determined. Only peptides with an xQuest score of higher than 15
are displayed as those cross-linking results are likely to be reliable
(see Text S1). The respective modified amino acid is displayed in
bold. Under ‘‘Monolink/Looplink’’ listed positions are the
absolute positions of the respective protein (including signal
peptides), ‘‘Error’’ the deviation of measured precursor ion mass
from theoretical precursor ion mass in parts per million, and
‘‘Score’’ the xQuest score.
Found at: doi:10.1371/journal.ppat.1000824.s010 (0.10 MB RTF)
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